Scott Morris, MD | |
48 Medical Park East Drive, Suite 255, Birmingham, AL 35235 | |
(205) 838-3090 | |
(205) 836-2954 |
Full Name | Scott Morris |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 37 Years |
Location | 48 Medical Park East Drive, Birmingham, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609835107 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 14529 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St. Vincent's East | Birmingham, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Alabama Orthopedic Spine And Sports Medicine Associates P C | 5395643068 | 40 |
News Archive
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,759,506 entitled "Bipolar Trans Carotenoid Salts and Their Uses." This patent includes drug formulation and use claims relating to Diffusion's entire family of first-in-class new chemical entities. Diffusion Pharmaceuticals is commercializing this family of first-in-class drug candidates to treat serious or life-threatening medical conditions characterized by hypoxia or oxygen deprivation at the cellular level.
SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2009. The Company will host a live conference call on March 31, 2010, at 11:30 a.m. (Eastern Standard Time).
When a thief breaks into a bank vault, sensors are activated and the alarm is raised. Cells have their own early-warning system for intruders, and scientists at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, have discovered how a particular protein sounds that alarm when it detects invading viruses.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 4 days ago
Entity Name | Alabama Orthopedic Spine & Sports Medicine Associates P C |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659344984 PECOS PAC ID: 5395643068 Enrollment ID: O20031219000647 |
News Archive
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,759,506 entitled "Bipolar Trans Carotenoid Salts and Their Uses." This patent includes drug formulation and use claims relating to Diffusion's entire family of first-in-class new chemical entities. Diffusion Pharmaceuticals is commercializing this family of first-in-class drug candidates to treat serious or life-threatening medical conditions characterized by hypoxia or oxygen deprivation at the cellular level.
SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2009. The Company will host a live conference call on March 31, 2010, at 11:30 a.m. (Eastern Standard Time).
When a thief breaks into a bank vault, sensors are activated and the alarm is raised. Cells have their own early-warning system for intruders, and scientists at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, have discovered how a particular protein sounds that alarm when it detects invading viruses.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 4 days ago
Entity Name | Orthosports Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114226438 PECOS PAC ID: 3173707171 Enrollment ID: O20110418000109 |
News Archive
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,759,506 entitled "Bipolar Trans Carotenoid Salts and Their Uses." This patent includes drug formulation and use claims relating to Diffusion's entire family of first-in-class new chemical entities. Diffusion Pharmaceuticals is commercializing this family of first-in-class drug candidates to treat serious or life-threatening medical conditions characterized by hypoxia or oxygen deprivation at the cellular level.
SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2009. The Company will host a live conference call on March 31, 2010, at 11:30 a.m. (Eastern Standard Time).
When a thief breaks into a bank vault, sensors are activated and the alarm is raised. Cells have their own early-warning system for intruders, and scientists at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, have discovered how a particular protein sounds that alarm when it detects invading viruses.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Scott Morris, MD 48 Medical Park East Drive, Suite 255, Birmingham, AL 35235 Ph: (205) 838-3090 | Scott Morris, MD 48 Medical Park East Drive, Suite 255, Birmingham, AL 35235 Ph: (205) 838-3090 |
News Archive
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,759,506 entitled "Bipolar Trans Carotenoid Salts and Their Uses." This patent includes drug formulation and use claims relating to Diffusion's entire family of first-in-class new chemical entities. Diffusion Pharmaceuticals is commercializing this family of first-in-class drug candidates to treat serious or life-threatening medical conditions characterized by hypoxia or oxygen deprivation at the cellular level.
SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2009. The Company will host a live conference call on March 31, 2010, at 11:30 a.m. (Eastern Standard Time).
When a thief breaks into a bank vault, sensors are activated and the alarm is raised. Cells have their own early-warning system for intruders, and scientists at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, have discovered how a particular protein sounds that alarm when it detects invading viruses.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 4 days ago
James Russell Bowman, M.D./ PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 200, Birmingham, AL 35205 Phone: 205-933-7838 | |
Jan Kenjiro Vonhoegen, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 720 Montclair Rd, Birmingham, AL 35213 Phone: 205-397-5200 Fax: 205-397-5220 | |
Victoria Masear, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 48 Medical Park E Dr, Suite 200, Birmingham, AL 35235 Phone: 205-838-3090 Fax: 205-838-6783 | |
Abhinav Agarwal, M.B.B.S. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S Fl 3, Birmingham, AL 35233 Phone: 205-801-8630 Fax: 205-975-9532 | |
Stephen Patrick Cowley, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 720 Montclair Rd, Suite101, Birmingham, AL 35213 Phone: 205-397-5200 Fax: 205-397-5210 | |
Chong Weng, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 510 20th St S, Birmingham, AL 35233 Phone: 205-930-8339 | |
Patrick Reid Peavy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1801 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3900 Fax: 205-838-3906 |